|
Name |
2-Heptyl-3-hydroxy-4-quinolone
|
| Molecular Formula | C16H21NO2 | |
| IUPAC Name* |
2-heptyl-3-hydroxy-1H-quinolin-4-one
|
|
| SMILES |
CCCCCCCC1=C(C(=O)C2=CC=CC=C2N1)O
|
|
| InChI |
InChI=1S/C16H21NO2/c1-2-3-4-5-6-11-14-16(19)15(18)12-9-7-8-10-13(12)17-14/h7-10,19H,2-6,11H2,1H3,(H,17,18)
|
|
| InChIKey |
CEIUIHOQDSVZJQ-UHFFFAOYSA-N
|
|
| Synonyms |
2-HEPTYL-3-HYDROXY-4-QUINOLONE; 2-heptyl-3-hydroxy-4(1H)-quinolone; 2-heptyl-3-hydroxy-1H-quinolin-4-one; 521313-35-9; 2-Heptyl-3-hydroxy-quinolone; Pseudomonas quinolone signal; 2-Heptyl-3-hydroxyl-4-quinolone; 2-HEPTYLQUINOLINE-3,4-DIOL; PQS; CHEMBL2426244; CHEBI:29472; 4(1H)-Quinolinone, 2-heptyl-3-hydroxy-; SCHEMBL130919; 3,4-dihydroxy-2-heptylquinoline; DTXSID00376772; ZINC8436860; BDBM50440134; AKOS015897030; SB71720; DA-26186; FT-0647383; FT-0761545; 2-nonylquinoline-3,4-diol:Series 3 HAQ C9; F16823; 985H279; J-002218; Q27110090; 2-Heptyl-3-hydroxy-4(1H)-quinolone, >=96.0% (HPLC); JWW
|
|
| CAS | 521313-35-9 | |
| PubChem CID | 2763159 | |
| ChEMBL ID | CHEMBL2426244 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 259.34 | ALogp: | 4.7 |
| HBD: | 2 | HBA: | 3 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 49.3 | Aromatic Rings: | 2 |
| Heavy Atoms: | 19 | QED Weighted: | 0.754 |
| Caco-2 Permeability: | -4.87 | MDCK Permeability: | 0.00001900 |
| Pgp-inhibitor: | 0.461 | Pgp-substrate: | 0.003 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.331 |
| 30% Bioavailability (F30%): | 0.208 |
| Blood-Brain-Barrier Penetration (BBB): | 0.16 | Plasma Protein Binding (PPB): | 97.39% |
| Volume Distribution (VD): | 0.594 | Fu: | 1.88% |
| CYP1A2-inhibitor: | 0.951 | CYP1A2-substrate: | 0.718 |
| CYP2C19-inhibitor: | 0.802 | CYP2C19-substrate: | 0.183 |
| CYP2C9-inhibitor: | 0.633 | CYP2C9-substrate: | 0.911 |
| CYP2D6-inhibitor: | 0.766 | CYP2D6-substrate: | 0.417 |
| CYP3A4-inhibitor: | 0.26 | CYP3A4-substrate: | 0.177 |
| Clearance (CL): | 2.339 | Half-life (T1/2): | 0.59 |
| hERG Blockers: | 0.056 | Human Hepatotoxicity (H-HT): | 0.105 |
| Drug-inuced Liver Injury (DILI): | 0.147 | AMES Toxicity: | 0.348 |
| Rat Oral Acute Toxicity: | 0.173 | Maximum Recommended Daily Dose: | 0.062 |
| Skin Sensitization: | 0.928 | Carcinogencity: | 0.138 |
| Eye Corrosion: | 0.041 | Eye Irritation: | 0.943 |
| Respiratory Toxicity: | 0.956 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004685 | ![]() |
0.441 | D04VKS | ![]() |
0.343 | ||
| ENC004179 | ![]() |
0.392 | D07UHS | ![]() |
0.318 | ||
| ENC000534 | ![]() |
0.391 | D0E7PQ | ![]() |
0.301 | ||
| ENC000617 | ![]() |
0.354 | D0E3SH | ![]() |
0.290 | ||
| ENC002006 | ![]() |
0.346 | D0P5GE | ![]() |
0.289 | ||
| ENC002935 | ![]() |
0.346 | D0V7XF | ![]() |
0.287 | ||
| ENC002793 | ![]() |
0.343 | D06CVT | ![]() |
0.286 | ||
| ENC002062 | ![]() |
0.341 | D0O2YE | ![]() |
0.286 | ||
| ENC000863 | ![]() |
0.341 | D06ZPS | ![]() |
0.284 | ||
| ENC004665 | ![]() |
0.337 | D0QV5T | ![]() |
0.281 | ||